-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Unicycive Therapeutics, Inc. annual/quarterly Revenues history and growth rate from Q3 2022 to Q1 2023.
- Unicycive Therapeutics, Inc. Revenues for the quarter ending March 31, 2023 was $675K.
- Unicycive Therapeutics, Inc. annual Revenues for 2023 was $675K, a 29% decline from 2022.